Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.

NCT04882475 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.

NCT NCT04882475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04882475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
Lead sponsor
Fondazione Italiana Linfomi - ETS
Phase
Observational
Overall status
Active, not recruiting
Start date
February 8, 2023
Completion date
April 30, 2026
Enrollment
160 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

mantle cell lymphoma